BFI Infinity Ltd. Invests $335,000 in DENTSPLY SIRONA Inc. $XRAY

Key Points

• BFI Infinity Ltd. invested $335,000 in DENTSPLY SIRONA Inc., acquiring 21,111 shares, as noted in their latest SEC filing.
• Analysts have mixed views on DENTSPLY SIRONA, with target price adjustments ranging from $19.00 to $15.00 and several ratings of "Hold" and "Buy."
• DENTSPLY SIRONA announced a quarterly dividend of $0.16, reflecting a 5.1% annualized yield, with an ex-dividend date of September 26th.

BFI Infinity Ltd. acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The firm acquired 21,111 shares of the medical instruments supplier's stock, valued at approximately $335,000.

A number of other large investors also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC raised its holdings in shares of DENTSPLY SIRONA by 222.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 38,786 shares of the medical instruments supplier's stock valued at $736,000 after buying an additional 26,748 shares during the period. GAMMA Investing LLC raised its holdings in shares of DENTSPLY SIRONA by 1,462.9% during the 1st quarter. GAMMA Investing LLC now owns 99,351 shares of the medical instruments supplier's stock valued at $1,484,000 after buying an additional 92,994 shares during the period. Merit Financial Group LLC purchased a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at about $548,000. Pallas Capital Advisors LLC raised its holdings in shares of DENTSPLY SIRONA by 222.5% during the 1st quarter. Pallas Capital Advisors LLC now owns 44,865 shares of the medical instruments supplier's stock valued at $670,000 after buying an additional 30,953 shares during the period. Finally, Sound Income Strategies LLC raised its holdings in shares of DENTSPLY SIRONA by 43.7% during the 1st quarter. Sound Income Strategies LLC now owns 347,841 shares of the medical instruments supplier's stock valued at $5,197,000 after buying an additional 105,777 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

XRAY has been the topic of several analyst reports. Stifel Nicolaus dropped their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a report on Friday, August 8th. Wall Street Zen upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday. Barrington Research dropped their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a report on Friday, August 8th. UBS Group lowered their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, August 8th. Two analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $18.64.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $12.61 on Tuesday. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.14 and a fifty-two week high of $27.16. The business has a 50 day moving average price of $14.08 and a two-hundred day moving average price of $14.79. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The firm has a market cap of $2.52 billion, a PE ratio of -2.66, a price-to-earnings-growth ratio of 0.78 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The business's revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a $0.16 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.1%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -13.50%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.